Other and unspecified malignant neoplasm of skin of lower limb, including hip
ICD-10 C44.7 is a billable code used to indicate a diagnosis of other and unspecified malignant neoplasm of skin of lower limb, including hip.
C44.7 refers to malignant neoplasms of the skin located on the lower limb, including the hip, that are not classified elsewhere. This category encompasses a variety of skin cancers, including but not limited to squamous cell carcinoma, basal cell carcinoma, and melanoma, which may arise due to factors such as chronic sun exposure, genetic predisposition, or other environmental influences. The diagnosis of skin cancer in this region often requires a thorough clinical examination, histopathological evaluation, and imaging studies to assess the extent of the disease. Surgical intervention is a common treatment modality, which may involve excision of the tumor with clear surgical margins to ensure complete removal of malignant cells. Reconstruction may be necessary depending on the size and location of the excised lesion, and it can involve techniques such as skin grafting or flap surgery. Accurate coding is essential for proper treatment planning, reimbursement, and tracking of cancer incidence and outcomes.
Detailed descriptions of lesions, biopsy results, and treatment plans.
Diagnosis and treatment of skin cancers, including Mohs micrographic surgery.
Ensure accurate coding based on histological findings and treatment modalities.
Comprehensive cancer staging, treatment plans, and follow-up care documentation.
Management of advanced skin cancers requiring systemic therapy.
Documentation must reflect the multidisciplinary approach to treatment.
Used for excision of malignant skin lesions on the lower limb.
Document size, location, and type of lesion excised.
Dermatology and surgical oncology should ensure accurate coding based on the procedure performed.
C44.7 includes various malignant neoplasms of the skin, such as squamous cell carcinoma, basal cell carcinoma, and melanoma, specifically located on the lower limb and hip.
A biopsy is typically required to confirm malignancy. Histopathological examination will provide definitive diagnosis and should be documented in the medical record.
